HIV Drug Resistance Testing Costing Tool
This tool was developed to support national HIV programs and ministries of health to estimate and compare the cost of the following two...
top of page
A framework to support new product introduction in national health systems
Resource Library
May 24, 2023
GAP-f pALD Introduction and Rollout Planning Considerations for National Programmes
The GAP-f pDTG task team has developed a brief outlining product introduction and rollout considerations for national programmes when...
550
Aug 16, 2021
Pediatric DTG Introduction: Transition Plan Templates
Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French
84
Jul 19, 2021
Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...
25
Feb 4, 2020
CHAI Cost of Optimizing Second-Line Treatment (COST) Tool
The CHAI COST Tool is a model that helps to estimate the financial impact of switching existing second-line (2L) patients to optimized,...
35
Dec 1, 2017
CHAI ARV Phase-In / Phase-Out Tool
As national programs introduce new, generic ARVs they must plan how and when the new product will be phased-in to ensure smooth and...
25
Nov 8, 2017
CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions
This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through...
23
Jul 22, 2016
Best Practices for New Product Introduction
This presentation from the 2016 International AIDS Society Conference outlines key approaches to product introduction, including working...
2
bottom of page